Minjuan Wu
- Cancer Research top 2%
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 5
- Genetics top 5%
- Mesenchymal stem cell research 18
- Rehabilitation top 2%
- Wound Healing and Treatments 15
- Molecular Biology top 5%
- Pluripotent Stem Cells Research 7
- Urology top 5%
- Hair Growth and Disorders 7
-
- Tissue Engineering and Regenerative Medicine 7
-
- Immune Cell Function and Interaction 4
- Journals
- Annals of Emergency Medicine (4 papers)Precision Clinical Medicine (3 papers)Cell Biology International (3 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Minjuan Wu
55 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Cancer Research 1.0k
- Genetics 349
- Rehabilitation 223
- Molecular Biology 1.6k
- Urology 95
Countries citing papers authored by Minjuan Wu
This map shows the geographic impact of Minjuan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minjuan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minjuan Wu more than expected).
Fields of papers citing papers by Minjuan Wu
This network shows the impact of papers produced by Minjuan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minjuan Wu. The network helps show where Minjuan Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Minjuan Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 14 | |
| 6 | 2024 | 31 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 14 | |
| 9 | 2020 | 3 | |
| 10 | 2019 | 11 | |
| 11 | 2018 | 20 | |
| 12 | 2016 | 11 | |
| 13 | 2016 | 11 | |
| 14 | 2016 | 85 | |
| 15 | 2015 | 1 | |
| 16 | 2013 | 2 | |
| 17 | Endogenous miRNA Sponge lincRNA-RoR Regulates Oct4, Nanog, and Sox2 in Human Embryonic Stem Cell Self-Renewalbreakdown → | 2013 | 652 |
| 18 | 2012 | 22 | |
| 19 | 2012 | 18 | |
| 20 | 2009 | 11 |
About Minjuan Wu
Minjuan Wu is a scholar working on Rehabilitation, Genetics and Urology, having authored 64 papers that have together received 2.2k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (18 papers), Wound Healing and Treatments (15 papers), MicroRNA in disease regulation (8 papers), Hair Growth and Disorders (7 papers), Tissue Engineering and Regenerative Medicine (7 papers), Pluripotent Stem Cells Research (7 papers), Cancer-related molecular mechanisms research (5 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Cancer Research (1.0k citations), Genetics (349 citations) and Rehabilitation (223 citations). Minjuan Wu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Houqi Liu, Chen Xu, Yue Wang, Jiuhong Kang, Junfeng Jiang, Jun Xiong, Zhenyu Xu, Xiaocan Guo, Lei Xiao and Kaihong Ji. Their work appears in journals such as Annals of Emergency Medicine, Precision Clinical Medicine, Cell Biology International, Journal of Clinical Laboratory Analysis and Journal of Environmental Management.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.